GB:0RK9 Stock Latest News
Company AnnouncementsAlligator Bioscience Sells Mitazalimab Rights to Biossil in Strategic Refocus on HLX221d ago
Company AnnouncementsAlligator Bioscience Boosts Share Count After Rights Issue2d ago
Company AnnouncementsAlligator Bioscience Plans 1-for-1,000 Reverse Share Split and Warrant Term Adjustments5d ago
Company AnnouncementsAlligator Bioscience Calls Extraordinary Meeting to Restructure Share Capital and Board5d ago- Company AnnouncementsAlligator Bioscience Refocuses Strategy on HLX22 and Bolsters Finances1w ago
Company AnnouncementsAlligator Bioscience to Present Q3 HER2-Focused Interim Report on 22 October2w agoCompany AnnouncementsAlligator Bioscience Names CFO Johan Giléus as CEO Amid Strategic Refocus on HLX224w ago
Company AnnouncementsAlligator Bioscience’s Rights Issue Heavily Reliant on Guarantees, Triggers Major Dilution1M ago- Company AnnouncementsAlligator Bioscience’s Rights Issue Undersubscribed, Underwriters Step In1M ago
Company AnnouncementsAlligator Bioscience Launches SEK 125.6 Million Rights Issue to Refocus Oncology Pipeline2M ago- Company AnnouncementsAlligator Bioscience Restructures Capital and Launches Major Rights Issue2M ago
Company AnnouncementsAlligator Bioscience exits mitazalimab development to refocus on HLX22 royalties and recapitalisation2M agoCompany AnnouncementsAlligator Bioscience Schedules August Earnings Call Amid Strategic Refocus2M ago
Company AnnouncementsAlligator Bioscience Calls Extraordinary Meeting to Restructure Capital and Approve Rights Issue3M ago
- Company AnnouncementsAlligator Bioscience Shifts Focus to HLX22 and Launches SEK 125.6 Million Rights Issue3M ago
- Company AnnouncementsAlligator Bioscience Backs Intratumoral Mitazalimab Study in Early Breast Cancer4M ago
- Company AnnouncementsAlligator Bioscience Sees Revenue Upside as HLX22 Global Phase 3 Reaches Key Milestone4M ago
- Company AnnouncementsAlligator Bioscience Sees Long-Term Revenue Potential in Henlius’ HLX22 Progress5M ago
Company AnnouncementsAlligator Bioscience AGM Backs Loss Carryforward and Expands Capital-Raising Mandate5M ago
Company AnnouncementsAlligator Bioscience Advances Oncology Pipeline and Bolsters Capital Base in Q1 20266M ago
Company AnnouncementsAlligator Bioscience Sets May 5 Earnings Call as Lead Cancer Drug Nears Phase 36M ago